In the literature, we found information indicating that positive associations were seen with the CHEK2 I157T missense variant and ovarian cystadenomas (OR = 1.7; p = 0.005), borderline ovarian cancers (OR = 2.6; p = 0.002), and low-grade invasive cancers (OR = 2.1; p = 0.04) [21]. Here, CHEK2 is linked to ovarian cystadenoma.